![Stefan Mathias Larson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stefan Mathias Larson
Directeur Général chez Mosaic Biomedicals SL
Fortune : 15 M $ au 31/05/2024
Postes actifs de Stefan Mathias Larson
Sociétés | Poste | Début | Fin |
---|---|---|---|
MaRS Discovery District
![]() MaRS Discovery District Miscellaneous Commercial ServicesCommercial Services MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | 02/10/2015 | - |
Mosaic Biomedicals SL
![]() Mosaic Biomedicals SL Hospital/Nursing ManagementHealth Services Mosaic Biomedicals SL develops personalized cancer treatments. It is engaged in the realization and development of scientific and technical research projects in the field of oncological and tumor diseases. The company was founded by Joan Seoane, Judit Anido Folgueira and José Baselga on April 19, 2013 and is headquartered in Barcelona, Spain. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - | |
eFFECTOR Therapeutics Operations, Inc.
![]() eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - | - |
Sectoral Asset Management Inc (Private Equity)
![]() Sectoral Asset Management Inc (Private Equity) Investment ManagersFinance Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec. | Private Equity Investor | 01/09/2018 | - |
Prilenia Therapeutics BV
![]() Prilenia Therapeutics BV BiotechnologyHealth Technology Prilenia Therapeutics BV develops and manufactures pharmaceuticals. The company was founded in 2018 and is headquartered in Naarden, the Netherlands. | Directeur/Membre du Conseil | - | - |
Turnstone Biologics, Inc.
![]() Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Directeur/Membre du Conseil | - | - |
MaRS Discovery District (Venture Capital)
![]() MaRS Discovery District (Venture Capital) Investment ManagersFinance MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - | - |
Apnimed, Inc.
![]() Apnimed, Inc. BiotechnologyHealth Technology Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 04/05/2022 | - |
Historique de carrière de Stefan Mathias Larson
Anciens postes connus de Stefan Mathias Larson
Sociétés | Poste | Début | Fin |
---|---|---|---|
TURNSTONE BIOLOGICS CORP. | Directeur/Membre du Conseil | 01/01/2019 | - |
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Stefan Mathias Larson
McGill University | Undergraduate Degree |
University of Toronto | Graduate Degree |
Stanford University | Doctorate Degree |
Statistiques
Internationale
Canada | 8 |
Etats-Unis | 6 |
Espagne | 2 |
Opérationnelle
Director/Board Member | 10 |
Chief Executive Officer | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 6 |
Consumer Services | 4 |
Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
TURNSTONE BIOLOGICS CORP. | Health Technology |
CONTINEUM THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 9 |
---|---|
MaRS Discovery District
![]() MaRS Discovery District Miscellaneous Commercial ServicesCommercial Services MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada. | Commercial Services |
Northern Biologics, Inc.
![]() Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Health Services |
Mosaic Biomedicals SL
![]() Mosaic Biomedicals SL Hospital/Nursing ManagementHealth Services Mosaic Biomedicals SL develops personalized cancer treatments. It is engaged in the realization and development of scientific and technical research projects in the field of oncological and tumor diseases. The company was founded by Joan Seoane, Judit Anido Folgueira and José Baselga on April 19, 2013 and is headquartered in Barcelona, Spain. | Health Services |
eFFECTOR Therapeutics Operations, Inc.
![]() eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Commercial Services |
Sectoral Asset Management Inc (Private Equity)
![]() Sectoral Asset Management Inc (Private Equity) Investment ManagersFinance Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec. | Finance |
Prilenia Therapeutics BV
![]() Prilenia Therapeutics BV BiotechnologyHealth Technology Prilenia Therapeutics BV develops and manufactures pharmaceuticals. The company was founded in 2018 and is headquartered in Naarden, the Netherlands. | Health Technology |
Turnstone Biologics, Inc.
![]() Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Health Technology |
MaRS Discovery District (Venture Capital)
![]() MaRS Discovery District (Venture Capital) Investment ManagersFinance MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada. | Finance |
Apnimed, Inc.
![]() Apnimed, Inc. BiotechnologyHealth Technology Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Stefan Mathias Larson
- Expérience